Page last updated: 2024-09-03

8-(4-carboxymethyloxy)phenyl-1,3-dipropylxanthine and enprofylline

8-(4-carboxymethyloxy)phenyl-1,3-dipropylxanthine has been researched along with enprofylline in 1 studies

Compound Research Comparison

Studies
(8-(4-carboxymethyloxy)phenyl-1,3-dipropylxanthine)
Trials
(8-(4-carboxymethyloxy)phenyl-1,3-dipropylxanthine)
Recent Studies (post-2010)
(8-(4-carboxymethyloxy)phenyl-1,3-dipropylxanthine)
Studies
(enprofylline)
Trials
(enprofylline)
Recent Studies (post-2010) (enprofylline)
16032204116

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jacobson, KA; Kim, HS; Kim, SA; Linden, J; Marshall, MA; Melman, N; Müller, CE1

Other Studies

1 other study(ies) available for 8-(4-carboxymethyloxy)phenyl-1,3-dipropylxanthine and enprofylline

ArticleYear
Structure-activity relationships at human and rat A2B adenosine receptors of xanthine derivatives substituted at the 1-, 3-, 7-, and 8-positions.
    Journal of medicinal chemistry, 2002, May-23, Volume: 45, Issue:11

    Topics: Animals; Binding, Competitive; Cell Line; Cloning, Molecular; Humans; Ligands; Purinergic P1 Receptor Antagonists; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A2B; Receptors, Purinergic P1; Recombinant Proteins; Structure-Activity Relationship; Xanthines

2002